+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
524218 RESONANCE

Resonance Specialties Share Price

 

 

Resonance Specialties live price: ₹130. It opened at ₹131 vs previous close ₹131; intraday high/low: ₹135/₹128. The 50 & 200 DMA stand at ₹115.36/₹104.07.

Resonance Specialties Performance

  • Today's Low
  • ₹128
  • Today's High
  • ₹135
  • 52 Week Low
  • ₹77
  • 52 Week High
  • ₹143
  • Open Price₹131
  • Previous Close₹131
  • Volume13,513
  • 50 DMA₹115.36
  • 100 DMA₹108.32
  • 200 DMA₹104.07

Resonance Specialties Chart

Investment Returns

  • Over 1 Month + 20.05%
  • Over 3 Month + 43.01%
  • Over 6 Month + 31.79%
  • Over 1 Year + 8.24%

Smart Investing Starts Here Start SIP with Resonance Specialties for Steady Growth!

Invest Now

Resonance Specialties Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 14.4
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 150
  • P/B Ratio
  • 2
  • Average True Range
  • 7.34
  • EPS
  • -
  • Dividend Yield
  • 0.8
  • MACD Signal
  • 6.47
  • RSI
  • 60.74
  • MFI
  • 53.5

Resonance Specialties Financials

Resonance Specialties Technicals

EMA & SMA

Current Price
₹130.00
-1.35 (-1.03%)
pointer
  • Bearish Moving Average 3
  • Bullish Moving Average 13
  • 20 Day
  • ₹125.70
  • 50 Day
  • ₹115.40
  • 100 Day
  • ₹108.30
  • 200 Day
  • ₹104.10

Resistance and Support

131.35 Pivot Speed
  • R3 142.30
  • R2 138.50
  • R1 135.15
  • S1 128.00
  • S2 124.20
  • S3 120.85

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Resonance Specialities has an operating revenue of Rs. 90.25 Cr. on a trailing 12-month basis. An annual revenue growth of 17% is outstanding, Pre-tax margin of 16% is great, ROE of 14% is good. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 20% and 29% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 11% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 57 which is a POOR score indicating inconsistency in earnings, a RS Rating of 88 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 43 indicates it belongs to a fair industry group of Chemicals-Specialty and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Resonance Specialties Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-14 Audited Results & Final Dividend
2026-02-04 Quarterly Results
2025-11-03 Quarterly Results
2025-08-05 Quarterly Results
2025-05-19 Audited Results & Final Dividend
Date Purpose Remarks
2026-07-28 FINAL Rs.1.00 per share(10%)Final Dividend
2025-07-29 FINAL Rs.1.00 per share(10%)Final Dividend
2022-08-05 FINAL Rs.1.00 per share(10%)Dividend
2021-08-20 FINAL Rs.1.00 per share(10%)Final Dividend
View Resonance Specialties Dividend History Arrow

Resonance Specialties Shareholding Pattern

54.25%
35.29%
10.46%

Resonance Specialties FAQs

Resonance Specialties share price is ₹130 As on 14 June, 2026 | 15:16

The Market Cap of Resonance Specialties is ₹150.1 Cr As on 14 June, 2026 | 15:16

The P/E ratio of Resonance Specialties is 14.4 As on 14 June, 2026 | 15:16

The PB ratio of Resonance Specialties is 2 As on 14 June, 2026 | 15:16

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23